First cancer gene therapy gets US go-ahead


US regulators on Wednesday approved the first gene therapy against cancer — a treatment that uses a patient’s own immune cells to fight leukemia — opening a new era in the fight against one of the world’s top killers. The treatment is made by Novartis and is called Kymriah (tisagenlecleucel). This type of anti-cancer immunotherapy, known…


First cancer gene therapy gets US go-ahead
First cancer gene therapy gets US go-ahead

Comments

Loading Facebook Comments ...
Loading Disqus Comments ...